Back to Search
Start Over
Therapeutic Potential of Antimicrobial Peptide PN5 against Multidrug-Resistant E. coli and Anti-Inflammatory Activity in a Septic Mouse Model.
- Source :
-
Microbiology spectrum [Microbiol Spectr] 2022 Oct 26; Vol. 10 (5), pp. e0149422. Date of Electronic Publication: 2022 Sep 21. - Publication Year :
- 2022
-
Abstract
- Antibiotic-resistant bacteria have become a public health problem. Thus, antimicrobial peptides (AMPs) have been evaluated as substitutes for antibiotics. Herein, we investigated PN5 derived from Pinus densiflora (pine needle). PN5 exhibited antimicrobial activity without causing cytotoxic effects. Based on these results, we examined the mode of action of PN5 against Gram-negative and -positive bacteria. PN5 exhibited membrane permeabilization ability, had antimicrobial stability in the presence of elastase, a proteolytic enzyme, and did not induce resistance in bacteria. Bacterial lipopolysaccharide (LPS) induces an inflammatory response in RAW 264.7 macrophages. PN5 suppressed proinflammatory cytokines mediated by NF-κB and mitogen-activated protein kinase signaling. In C57BL/6J mice treated with LPS and d-galactosamine, PN5 exhibited anti-inflammatory activity in inflamed mouse livers. Our results indicate that PN5 has antimicrobial and anti-inflammatory activities and thus may be useful as an antimicrobial agent to treat septic shock caused by multidrug-resistant (MDR) Escherichia coli without causing further resistance. IMPORTANCE Antibiotic-resistant bacteria are a global health concern. There is no effective treatment for antibiotic-resistant bacteria, and new alternatives are being suggested. The present study found antibacterial and anti-inflammatory activities of PN5 derived from Pinus densiflora (pine needle), and further investigated the therapeutic effect in a mouse septic model. As a mechanism of antibacterial activity, PN5 exhibited the membrane permeabilization ability of the toroidal model, and treated strains did not develop drug resistance during serial passages. PN5 showed immunomodulatory properties of neutralizing LPS in a mouse septic model. These results indicate that PN5 could be a new and promising therapeutic agent for bacterial infectious disease caused by antibiotic-resistant strains.
- Subjects :
- Mice
Animals
Escherichia coli
Lipopolysaccharides
Antimicrobial Peptides
NF-kappa B pharmacology
NF-kappa B therapeutic use
Mice, Inbred C57BL
Anti-Bacterial Agents pharmacology
Anti-Bacterial Agents therapeutic use
Anti-Inflammatory Agents pharmacology
Anti-Inflammatory Agents therapeutic use
Disease Models, Animal
Bacteria
Galactosamine pharmacology
Galactosamine therapeutic use
Pancreatic Elastase pharmacology
Pancreatic Elastase therapeutic use
Peptide Hydrolases pharmacology
Peptide Hydrolases therapeutic use
Cytokines
Mitogen-Activated Protein Kinases
Microbial Sensitivity Tests
Shock, Septic drug therapy
Anti-Infective Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 2165-0497
- Volume :
- 10
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Microbiology spectrum
- Publication Type :
- Academic Journal
- Accession number :
- 36129300
- Full Text :
- https://doi.org/10.1128/spectrum.01494-22